Dr. Donaldson received his MD-PhD in 1992 from McMaster University in Hamilton, Ontario, where he studied at the Michael G. DeGroote School of Medicine. Prior to spending three years as a psychiatry resident at Columbia University and the New York State Psychiatric Institute, he completed a year of internal medicine training at the Juravinski Hospital.
Later, Dr. Donaldson relocated to Austin, Texas, for the remainder of his residency. Additionally, he was a research fellow at the Dell Medical School’s Center for Psychedelic Research & Therapy, where his work advanced the use of psychedelics in the treatment of mental health conditions.
Currently, Dr. Donaldson serves on the board of the American Academy of Research on Psychedelics (AAP) and the Center for Neuroscience of Psychedelics (CNP), as a forerunner in the development of psychedelic healthcare and a leader in disseminating best practices to professionals in the fields of medicine and mental health.
Education & Training:
Michael G. DeGroote School of Medicine, MD/PhD – 1992
McMaster University, PhD (Neuroscience) – 1991
Internship – Internal Medicine, Juravinski Hospital
Residency – Texas Health Arlington Memorial Hospital
Research Fellowship – Dell Medical School’ Center for Psychedelic Research & Therapy
Postdoctoral – Center for Neuroscience of Psychedelics
About our Medical Review Process:
SDC is dedicated to employing only the highest safety protocols with all of our products. To guarantee that our customers receive the highest level of quality and safety, each product is thoroughly tested in a secure, accredited laboratory setting.
For assistance, simply get in touch with support. Our staff is dedicated to giving accurate, evidence-based information about psychedelics.
“Here at SDCTM the development of our products, here at SDCTM are based on utilization of comprehensive, substantiated, and scientifically sound clinical evidence.
We hope to advance the use of psychedelics for the treatment of mental health issues. By utilizing and spreading accurate, reliable, and scientifically sound content, our objective is to disseminate knowledge concerning psychedelic medicine and its potential to revolutionize mental healthcare” – Dr. Donaldson